Spero Therapeutics Inc (SPRO)
1.25
-0.06
(-4.58%)
USD |
NASDAQ |
Nov 14, 12:16
Spero Therapeutics Profit Margin (Quarterly): -296.9% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -296.9% |
| March 31, 2024 | -301.4% |
| December 31, 2023 | 71.27% |
| September 30, 2023 | -13.71% |
| June 30, 2023 | -1.51K% |
| March 31, 2023 | -1.79K% |
| December 31, 2022 | 57.75% |
| September 30, 2022 | -1.08K% |
| June 30, 2022 | -3.20K% |
| March 31, 2022 | -13.29K% |
| December 31, 2021 | -11.42K% |
| September 30, 2021 | -3.18K% |
| June 30, 2021 | -881.9% |
| Date | Value |
|---|---|
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | -474.0% |
| June 30, 2020 | -1.01K% |
| March 31, 2020 | -1.37K% |
| December 31, 2019 | |
| September 30, 2019 | -381.6% |
| June 30, 2019 | -609.9% |
| March 31, 2019 | -133.2% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -2.15K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-13.29K%
Minimum
Mar 2022
71.27%
Maximum
Dec 2023
-2.48K%
Average
-1.05K%
Median
Profit Margin (Quarterly) Benchmarks
| Arbutus Biopharma Corp | -1.47K% |
| Equillium Inc | 3.38% |
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 22.26% |
| Return on Assets | 12.36% |
| Return on Invested Capital | 22.26% |
| Operating Margin (Quarterly) | -316.8% |
| Return on Net Operating Assets | 46.45% |